Cargando…
Interaction Between Florfenicol and Doxycycline Involving Cytochrome P450 3A in Goats (Capra hricus)
When two drugs are combined, drug-drug interactions (DDI) often occur. Metabolic DDI usually occur due to inhibition of the metabolism of one drug by the other. This leads to an increase in the plasma concentration of the drug whose metabolism is inhibited. The objective of this research study was t...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558239/ https://www.ncbi.nlm.nih.gov/pubmed/34733909 http://dx.doi.org/10.3389/fvets.2021.759716 |
_version_ | 1784592512771424256 |
---|---|
author | Wang, Xiaojing Yang, Yaqin Martínez, María-Aránzazu Martínez, Marta Lopez-Torres, Bernardo Martínez-Larrañaga, María-Rosa Wang, Xu Anadón, Arturo Ares, Irma |
author_facet | Wang, Xiaojing Yang, Yaqin Martínez, María-Aránzazu Martínez, Marta Lopez-Torres, Bernardo Martínez-Larrañaga, María-Rosa Wang, Xu Anadón, Arturo Ares, Irma |
author_sort | Wang, Xiaojing |
collection | PubMed |
description | When two drugs are combined, drug-drug interactions (DDI) often occur. Metabolic DDI usually occur due to inhibition of the metabolism of one drug by the other. This leads to an increase in the plasma concentration of the drug whose metabolism is inhibited. The objective of this research study was to verify the DDI risk of two antibacterial, florfenicol (FF) and doxycycline (DOX) due to metabolism. Because food containing residues of any pharmacologically active substance could potentially constitute a public health hazard, we selected a food producing animal, goat, goat liver microsomes and recombinant metabolic enzymes, for in vivo and in vitro metabolism studies. In vitro experiments showed that CYP3A was the key enzyme subfamily in FF metabolism, DOX slowed down FF metabolism and R440 was possibly the key amino acid in the metabolic interaction between FF and DOX. In vivo studies in the goats showed that DOX inhibited up-regulation of CYP3A24 gene expression produced by FF; in liver and kidney, DOX slightly slowed down FF metabolism. Quantitative prediction of DDI risk suggest that when DOX is used in combination with FF in veterinary medicine, may result in a clinical significant increase of FF plasma and tissue concentrations, resulting a prevalence of harmful tissue residues of medicinal products in the food chain. Through our experimentation, when DOX is used in combination with FF, the withdrawal period of FF in the kidney was extended by 1 day. Otherwise, an appropriate withdrawal period (20 days) of FF was established for FF and DOX combined use to ensure that the animal can be safely slaughtered for food. |
format | Online Article Text |
id | pubmed-8558239 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85582392021-11-02 Interaction Between Florfenicol and Doxycycline Involving Cytochrome P450 3A in Goats (Capra hricus) Wang, Xiaojing Yang, Yaqin Martínez, María-Aránzazu Martínez, Marta Lopez-Torres, Bernardo Martínez-Larrañaga, María-Rosa Wang, Xu Anadón, Arturo Ares, Irma Front Vet Sci Veterinary Science When two drugs are combined, drug-drug interactions (DDI) often occur. Metabolic DDI usually occur due to inhibition of the metabolism of one drug by the other. This leads to an increase in the plasma concentration of the drug whose metabolism is inhibited. The objective of this research study was to verify the DDI risk of two antibacterial, florfenicol (FF) and doxycycline (DOX) due to metabolism. Because food containing residues of any pharmacologically active substance could potentially constitute a public health hazard, we selected a food producing animal, goat, goat liver microsomes and recombinant metabolic enzymes, for in vivo and in vitro metabolism studies. In vitro experiments showed that CYP3A was the key enzyme subfamily in FF metabolism, DOX slowed down FF metabolism and R440 was possibly the key amino acid in the metabolic interaction between FF and DOX. In vivo studies in the goats showed that DOX inhibited up-regulation of CYP3A24 gene expression produced by FF; in liver and kidney, DOX slightly slowed down FF metabolism. Quantitative prediction of DDI risk suggest that when DOX is used in combination with FF in veterinary medicine, may result in a clinical significant increase of FF plasma and tissue concentrations, resulting a prevalence of harmful tissue residues of medicinal products in the food chain. Through our experimentation, when DOX is used in combination with FF, the withdrawal period of FF in the kidney was extended by 1 day. Otherwise, an appropriate withdrawal period (20 days) of FF was established for FF and DOX combined use to ensure that the animal can be safely slaughtered for food. Frontiers Media S.A. 2021-10-18 /pmc/articles/PMC8558239/ /pubmed/34733909 http://dx.doi.org/10.3389/fvets.2021.759716 Text en Copyright © 2021 Wang, Yang, Martínez, Martínez, Lopez-Torres, Martínez-Larrañaga, Wang, Anadón and Ares. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Veterinary Science Wang, Xiaojing Yang, Yaqin Martínez, María-Aránzazu Martínez, Marta Lopez-Torres, Bernardo Martínez-Larrañaga, María-Rosa Wang, Xu Anadón, Arturo Ares, Irma Interaction Between Florfenicol and Doxycycline Involving Cytochrome P450 3A in Goats (Capra hricus) |
title | Interaction Between Florfenicol and Doxycycline Involving Cytochrome P450 3A in Goats (Capra hricus) |
title_full | Interaction Between Florfenicol and Doxycycline Involving Cytochrome P450 3A in Goats (Capra hricus) |
title_fullStr | Interaction Between Florfenicol and Doxycycline Involving Cytochrome P450 3A in Goats (Capra hricus) |
title_full_unstemmed | Interaction Between Florfenicol and Doxycycline Involving Cytochrome P450 3A in Goats (Capra hricus) |
title_short | Interaction Between Florfenicol and Doxycycline Involving Cytochrome P450 3A in Goats (Capra hricus) |
title_sort | interaction between florfenicol and doxycycline involving cytochrome p450 3a in goats (capra hricus) |
topic | Veterinary Science |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558239/ https://www.ncbi.nlm.nih.gov/pubmed/34733909 http://dx.doi.org/10.3389/fvets.2021.759716 |
work_keys_str_mv | AT wangxiaojing interactionbetweenflorfenicolanddoxycyclineinvolvingcytochromep4503aingoatscaprahricus AT yangyaqin interactionbetweenflorfenicolanddoxycyclineinvolvingcytochromep4503aingoatscaprahricus AT martinezmariaaranzazu interactionbetweenflorfenicolanddoxycyclineinvolvingcytochromep4503aingoatscaprahricus AT martinezmarta interactionbetweenflorfenicolanddoxycyclineinvolvingcytochromep4503aingoatscaprahricus AT lopeztorresbernardo interactionbetweenflorfenicolanddoxycyclineinvolvingcytochromep4503aingoatscaprahricus AT martinezlarranagamariarosa interactionbetweenflorfenicolanddoxycyclineinvolvingcytochromep4503aingoatscaprahricus AT wangxu interactionbetweenflorfenicolanddoxycyclineinvolvingcytochromep4503aingoatscaprahricus AT anadonarturo interactionbetweenflorfenicolanddoxycyclineinvolvingcytochromep4503aingoatscaprahricus AT aresirma interactionbetweenflorfenicolanddoxycyclineinvolvingcytochromep4503aingoatscaprahricus |